Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nektaria, Andronikou"'
Autor:
Eguchi, Akiko, De Mollerat Du Jeu, Xavier, Johnson, Casey D., Nektaria, Andronikou, Feldstein, Ariel E.
Publikováno v:
In Journal of Hepatology March 2016 64(3):699-707
Publikováno v:
Cell and Gene Therapy Insights. :627-639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00c6452c353d29b25bff1054332802b5
https://doi.org/10.18609/cgti.2022.092
https://doi.org/10.18609/cgti.2022.092
Autor:
M. Neal, Nektaria Andronikou, X. de Mollerat du Jeu, Namritha Ravinder, Y. Zou, W. Lee, M. La Course
Publikováno v:
Cytotherapy. 22:S206
Background & Aim Crispr-Cas9 based gene modification is gaining traction in the field of cell-based immunotherapy as a safe non-viral alternative to lentiviral vectors which are currently utilized to manufacture the approved FDA Car-T therapies. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dd78f3ef9ba89e5fb2250a52b8c68e5
https://doi.org/10.1016/j.jcyt.2020.04.086
https://doi.org/10.1016/j.jcyt.2020.04.086
Autor:
Sean Chang, Xin Yu, Yongchang Ji, Xiquan Liang, Nektaria Andronikou, Xavier de Mollerat du Jeu
Publikováno v:
The Journal of Immunology. 200:179.14-179.14
The successes of chimeric antigen receptor (CAR) T cells in treating blood cancers have highlighted the cell therapy era. However, the difficulty of delivering molecules into immune cells has been an obstacle to more rapid advancement. Here we presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba038ceddaf601370078c638970461ec
https://doi.org/10.4049/jimmunol.200.supp.179.14
https://doi.org/10.4049/jimmunol.200.supp.179.14
Publikováno v:
The Journal of Immunology. 198:73.24-73.24
The successful cases of autologous CAR-T cell therapy in leukemia have highlighted the promising future of cell therapy. However, most studies in this field have been using viruses to engineer T cells, which lead to safety concerns. On the other hand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfbcd29fb253c002f5da0f4e821281af
https://doi.org/10.4049/jimmunol.198.supp.73.24
https://doi.org/10.4049/jimmunol.198.supp.73.24
Autor:
Chu-Tan, Joshua A., Nilisha Fernando, Riemke Aggio-Bruce, Cioanca, Adrian V., Krisztina Valter, Nektaria Andronikou, Xavier Demollerat du Jeu, Matthew Rutar, Jan Provis, Riccardo Natoli
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
University of Canberra
Molecular Vision
Scopus-Elsevier
University of Canberra
Molecular Vision
Purpose The use of small non-coding nucleic acids, such as siRNA and miRNA, has allowed for a deeper understanding of gene functions, as well as for development of gene therapies for complex neurodegenerative diseases, including retinal degeneration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::38fac309974a0c3ccfeec4e5155b3207
http://europepmc.org/abstract/med/32165826
http://europepmc.org/abstract/med/32165826
